Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
22 07 2023
Historique:
received: 29 06 2023
revised: 15 07 2023
accepted: 20 07 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

There are different cancers in the peri-ampullary region, including pancreatic ductal adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma (AAC). Here, significant morphological-molecular characterizations should be necessary for the distinction of primary tumours and classifications of their subtypes of cancers. The sub classification of AACs might include up to five different variants, according to different points of view, concerning the prevalence of the two more-cellular components found in the ampulla. In particular, regarding the AACs, the most important subtypes are represented by the intestinal (INT) and the pancreato-biliary (PB) ones. The subtyping of AACs is essential for diagnosis, and their identifications have been impacting clinical management responses to treatments and overall survival (os) after surgery. Pb is associated with a worse clinical outcome. Otherwise, the criteria, through which are possible to attribute its subtype classification, are not well established. A triage of immune markers represented by CK7, CK20, and CDX-2 seem to represent the best compromise in order to split the cohort of AAC patients in the INT and PB groups. The test of choice for the sub-classification of AACs is represented by the immuno-histochemical approach, in which its molecular classification acquires its diagnostic, predictive, and prognostic value for both the INT and PB patients.

Identifiants

pubmed: 37504367
pii: curroncol30070507
doi: 10.3390/curroncol30070507
pmc: PMC10378042
doi:

Substances chimiques

Biomarkers, Tumor 0
Lead 2P299V784P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6996-7006

Références

Trends Genet. 1993 Apr;9(4):138-41
pubmed: 8516849
Am J Surg Pathol. 2005 Mar;29(3):359-67
pubmed: 15725805
Hum Pathol. 2023 Feb;132:176-182
pubmed: 35714836
Pancreatology. 2019 Mar;19(2):316-324
pubmed: 30713128
J Clin Oncol. 2005 Mar 20;23(9):1811-8
pubmed: 15774774
Surg Pathol Clin. 2020 Sep;13(3):453-467
pubmed: 32773194
Eur J Surg Oncol. 2018 May;44(5):677-683
pubmed: 29506768
J Hepatobiliary Pancreat Surg. 2004;11(5):301-9
pubmed: 15549428
J Clin Oncol. 2013 Apr 1;31(10):1348-56
pubmed: 23439753
J Clin Oncol. 2009 Jun 1;27(16):2598-603
pubmed: 19164203
Korean J Intern Med. 2007 Mar;22(1):55-8
pubmed: 17427649
Am J Surg Pathol. 2012 Nov;36(11):1592-608
pubmed: 23026934
Int J Oncol. 2002 Oct;21(4):769-74
pubmed: 12239615
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Pancreas. 2014 Jul;43(5):692-7
pubmed: 24713843
Ann Surg. 2015 Jul;262(1):47-52
pubmed: 25775067
Pancreatology. 2020 Apr;20(3):433-441
pubmed: 31987649
J Surg Oncol. 2018 Jun;117(7):1500-1508
pubmed: 29518820
Cancer. 1992 Jul 15;70(2):410-4
pubmed: 1617591
Ann Surg Oncol. 2012 May;19(5):1535-40
pubmed: 22045467
Am J Dermatopathol. 2018 Oct;40(10):758-761
pubmed: 29672360
Jpn J Cancer Res. 1996 Jun;87(6):631-40
pubmed: 8766528
Am J Surg. 2017 Nov;214(5):856-861
pubmed: 28285709
J Surg Oncol. 2012 Mar;105(3):266-72
pubmed: 21882202
Am J Surg Pathol. 2014 Oct;38(10):1371-9
pubmed: 24832159
Virchows Arch. 2007 Sep;451(3):649-57
pubmed: 17653761
BMJ Case Rep. 2012 Jul 03;2012:
pubmed: 22761197
J Am Coll Surg. 2008 Aug;207(2):210-8
pubmed: 18656049
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
Pancreatology. 2017 Mar - Apr;17(2):273-278
pubmed: 28131524
Int J Cancer. 2021 Mar 1;148(5):1040-1050
pubmed: 32674220
Cancer Med. 2019 Jul;8(7):3464-3470
pubmed: 31102323
BMC Gastroenterol. 2015 Nov 24;15:165
pubmed: 26603157
Clin Transl Oncol. 2018 Sep;20(9):1212-1218
pubmed: 29497964
Sci Rep. 2019 Sep 3;9(1):12676
pubmed: 31481741
J Gastrointest Surg. 2011 Aug;15(8):1411-6
pubmed: 21523621
Am J Surg Pathol. 2009 May;33(5):691-704
pubmed: 19252434
Am J Surg Pathol. 2015 Dec;39(12):1730-41
pubmed: 26559377
Br J Cancer. 2015 Jun 30;113(1):64-8
pubmed: 25989273
BMC Cancer. 2008 Sep 01;8:251
pubmed: 18761739
Clin Transl Oncol. 2020 Aug;22(8):1407-1413
pubmed: 31927720
PLoS One. 2016 Mar 14;11(3):e0151406
pubmed: 26974670
Mod Pathol. 2016 Dec;29(12):1575-1585
pubmed: 27586202
Ann Surg Oncol. 2013 Feb;20(2):430-9
pubmed: 22956064
Surgery. 2015 Jul;158(1):151-61
pubmed: 25819575
J Gastrointest Surg. 2010 Apr;14(4):719-28
pubmed: 20107918
Eur J Surg Oncol. 2020 Sep;46(9):1717-1726
pubmed: 32624291
J Surg Oncol. 2009 Dec 1;100(7):598-605
pubmed: 19697352
JAMA. 2012 Jul 11;308(2):147-56
pubmed: 22782416
Ochsner J. 2017 Winter;17(4):426-429
pubmed: 29230130
Ann Surg. 1913 Mar;57(3):402-26
pubmed: 17862983
J Gastrointest Surg. 2018 Apr;22(4):695-702
pubmed: 29127604
Mod Pathol. 2000 Dec;13(12):1300-7
pubmed: 11144926
Radiat Oncol. 2011 Sep 28;6:126
pubmed: 21951377
PLoS One. 2016 Nov 9;11(11):e0166067
pubmed: 27829047
Jpn J Cancer Res. 1994 Feb;85(2):161-6
pubmed: 7511574
Cancer. 2017 May 15;123(6):1011-1017
pubmed: 27859010
World J Gastroenterol. 2020 Nov 21;26(43):6822-6836
pubmed: 33268964
Ann Surg. 2020 Dec;272(6):1086-1093
pubmed: 30628913
Arch Pathol Lab Med. 2009 Jan;133(1):67-71
pubmed: 19123739
Virchows Arch. 2002 Jul;441(1):19-24
pubmed: 12111196
J Am Coll Surg. 2006 Jan;202(1):112-9
pubmed: 16377504
Br J Surg. 2020 Aug;107(9):1171-1182
pubmed: 32259295

Auteurs

Gennaro Nappo (G)

Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.

Niccola Funel (N)

USL Toscana Nordovest, Chemical-Clinical Analysis Laboratory, Department of Diagnostics, 56121 Pisa, Italy.

Virginia Laurenti (V)

Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.

Elisabetta Stenner (E)

USL Toscana Nordovest, Chemical-Clinical Analysis Laboratory, Department of Diagnostics, 56121 Pisa, Italy.

Silvia Carrara (S)

Endoscopic Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.

Silvia Bozzarelli (S)

Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.

Paola Spaggiari (P)

Pathology Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.

Alessandro Zerbi (A)

Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, 20089 Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH